Plantar Fasciitis Treatment Market to Reach USD 1.1 Billion by 2031 Amid Rising Obesity Rates and Increased Adoption of Hospital-Based Care | TMR

The global Plantar Fasciitis Treatment Market, valued at US$ 778.3 million in 2022, is projected to grow steadily and reach US$ 1.1 billion by 2031, recording a CAGR of 4.3% from 2023 to 2031. According to a newly released industry report, the surge in global obesity trends, rising preference for hospitalization over self-managed therapy, and accelerating technological advancements in orthotics and shockwave therapy are driving the market forward.

Access key findings and insights from our Report in this sample -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=47658

Plantar fasciitis remains one of the most common causes of heel pain worldwide, affecting both general populations and athletes. As lifestyle-related disorders and physical strain become more prevalent, healthcare providers, medical device manufacturers, and pharmaceutical companies are advancing comprehensive treatment solutions ranging from medication therapies to customized orthotics, minimally invasive procedures, and regenerative therapies.

Market Size & Future Outlook

The market's transition from traditional pain relief methods toward technologically advanced, personalized treatments is reshaping competitive dynamics. With more than 1 billion people worldwide classified as obese and millions engaging in intensive sports activities, demand for targeted plantar fasciitis therapies continues to rise. Strong healthcare infrastructure in developed regions, coupled with growing awareness and diagnostic precision in emerging economies, further strengthens the market outlook through 2031.

Market Overview

Plantar fasciitis occurs when the plantar fascia ligament, a vital connective tissue supporting the foot arch, becomes inflamed or strained. The condition affects an estimated one million individuals annually, with higher prevalence among obese individuals, professional athletes, long-distance runners, and aging populations.

Treatment approaches include:

Medication Therapy: NSAIDs, steroids, and analgesics

Orthotics: Customized and pre-fabricated insoles

Shockwave Therapy: ESWT, IPST

Surgery: Reserved for chronic, treatment-resistant cases

Others: Stretching, gastrocnemius recession, physical therapy, platelet-rich plasma injections, and foot taping

As medical device companies innovate in orthotic design, compression kits, and shockwave therapy, patients now have access to more comfortable, effective, and faster recovery options.

Key Market Growth Drivers

1. Escalation in Global Obesity Rates
A sedentary lifestyle, particularly accelerated during and after the COVID-19 pandemic, has led to unprecedented increases in obesity. Excessive weight puts undue stress on the plantar fascia, significantly elevating the risk of inflammation.

According to WHO, over 1 billion individuals are obese, dramatically expanding the patient pool.

Healthcare specialists highlight that individuals with a BMI ≥ 30 face a sixfold increased risk of developing plantar fasciitis.

2. Increasing Preference for Hospital-Based Care
Patients are increasingly choosing hospital-administered therapies for continuous monitoring, precise diagnostics, and access to advanced treatment options such as invasive procedures, steroid administration, and shockwave therapy.
Hospitalization also allows immediate decision-making for surgeries when chronic pain persists despite conservative interventions.

3. Technological Advancements in Orthotics and Shockwave Devices
Leading players are developing personalized orthotic devices tailored to patients' biomechanics.
Innovations include:

Night splints promoting passive stretching

Compression sock systems for pain relief (e.g., Atlecko's 12-piece kit)

Combination shockwave + vibration devices for chronic pain

4. Rising Sports Participation Worldwide
Professional athletes and recreational runners exhibit high vulnerability to plantar fascia injuries due to repetitive foot strain. Increasing investments in sports medicine and early-stage diagnosis contribute to sustained market growth.

Explore our report to uncover in-depth insights -

https://www.transparencymarketresearch.com/plantar-fasciitis-market.html

Analysis of Key Players & Their Strategic Approaches

The plantar fasciitis treatment market is moderately fragmented, with a mix of pharmaceutical giants, specialized orthotics companies, and medical device innovators.

Key Companies Profiled

Hanger, Inc.

Bayer Group (Dr. Scholl's)

A. Algeo Limited

Bauerfeind AG

Superfeet Worldwide, Inc.

Ottobock SE & Co. KGaA

Pfizer, Inc.

Sanofi

GlaxoSmithKline plc

Strategic Themes Driving Competition

1. Product Innovation & Customized Therapies
Companies are introducing bespoke orthotics designed based on personal clinical specifications and 3D foot scanning. Night splints like Ottobock's Malleo Immobil demonstrate the push toward ergonomically superior devices.

2. Strengthening R&D and Evidence-Based Solutions
Players are integrating evidence-backed mechanisms such as extracorporeal shockwave devices and regenerative therapies to address chronic plantar fasciitis cases more effectively.

3. Expanding Distribution Networks
Global brands are expanding their presence through hospital partnerships, online distribution channels, sports medicine franchises, and orthopedic specialty clinics.

4. Mergers, Acquisitions, and Collaborations
Strategic partnerships with technology developers, material science innovators, and sports rehabilitation centers remain crucial to maintaining competitiveness.

Market Challenges & Opportunities

Challenges

High variability in treatment outcomes across conservative therapies

Side effects associated with long-term NSAID or steroid use

Limited reimbursement policies for orthotics and shockwave therapy in certain markets

Lack of awareness in developing regions regarding early diagnosis

Opportunities
Growing demand for non-invasive treatments as patients avoid surgery

Rising online commerce channels enabling wider reach for orthotics and supportive devices

Increasing investments in biomechanics research supporting advanced orthotic development

Growing popularity of regenerative therapies, including PRP and stem cell protocols

Recent Developments

Atlecko Launches Compression Sock Kit (June 2022)
Atlecko introduced its scientifically engineered 12-piece plantar fasciitis sock kit, targeting improved pain relief and circulation management.

Ottobock Develops New Night Splints
Ottobock's Malleo Immobil Night Splint is designed to facilitate nighttime healing by providing consistent stretch to the plantar fascia.

Shockwave Therapy Device Enhancements

Several manufacturers are investing in hybrid shockwave systems that combine pneumatic and acoustic waves with localized vibration for faster, more effective pain resolution.

Investment Landscape and ROI Outlook

The plantar fasciitis treatment market presents a stable, medium-growth ROI environment, with attractive opportunities in:

1. Medical Device Manufacturing
Strong returns are expected in the development of 3D-printed orthotics, shockwave devices, and compression technologies.

2. Pharmaceuticals
Demand for anti-inflammatory drugs and analgesic therapies continues to rise, ensuring sustained pharmaceutical revenues.

3. Sports Medicine & Rehabilitation
Private clinics and sports therapy centers are increasingly investing in advanced diagnosis and treatment technologies.

4. Wellness & E-commerce Retail
Over-the-counter insoles, mobility devices, and compression apparel have significant revenue potential, especially in North America and Europe.

With continuous technological evolution, investors can expect consistent long-term yields, especially in device innovation and specialty footcare solutions.

Market Segmentations (With Regional Overview)

By Type

Medication Therapy

Oral

Parenteral

Orthotics

Shockwave Therapy

ESWT

IPST

Surgery

Others

By End-user

Hospitals

Clinics

Others

By Region

North America (Leading Region)

Strong healthcare infrastructure

High obesity incidence

High adoption of orthotics and shockwave devices

Europe

Significant patient base

Increasing sports-related injuries

Strong clinical research environment

Asia Pacific

Rising awareness

Growing medical tourism

Expanding hospital networks

Latin America

Steady growth in chronic disease management

Increasing adoption of orthotics

Middle East & Africa
Improving healthcare access

Growing obesity rates in GCC countries

Why Buy This Report?

Detailed quantitative and qualitative market insights from 2017-2031

Comprehensive segmentation and regional analysis

Coverage of market trends, drivers, and restraints

In-depth competitive landscape profiling major players

Analysis of technological innovations and regulatory impacts

Reliable data for investment planning and strategic decision-making

Buy this Premium Research Report for exclusive, in-depth insights -

https://www.transparencymarketresearch.com/checkout.php?rep_id=47658<ype=S

FAQs

1. What is plantar fasciitis and why is it increasing?
Plantar fasciitis is the inflammation of the plantar fascia ligament, commonly caused by obesity, overuse, prolonged standing, athletic strain, and aging.

2. Which treatment type dominates the market?
Orthotics and medication therapy remain the most commonly adopted treatments, though shockwave therapy is gaining rapid popularity.

3. Which region leads the global market?
North America dominates due to high obesity rates, strong healthcare infrastructure, and early adoption of advanced therapies.

4. What innovations are shaping the industry?
Advancements include 3D-printed orthotics, combination shockwave devices, compression systems, and regenerative therapies like PRP.

5. Who are the major players?
Key players include Hanger, Bayer Group (Dr. Scholl's), Bauerfeind AG, Ottobock, Pfizer, Sanofi, and GSK.

Explore Latest Research Reports by Transparency Market Research:

Oligonucleotides Market - https://www.transparencymarketresearch.com/oligonucleotides-market.html

Syphilis Diagnostics Market - https://www.transparencymarketresearch.com/syphilis-diagnostics-market.html

Lung Cancer Diagnostics Market - https://www.transparencymarketresearch.com/lung-cancer-diagnostics-market.html

Peptide API Market - https://www.transparencymarketresearch.com/peptide-api-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.